There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Denali Therapeutics (DNLI – Research Report), Ardent Health Partners, Inc. (ARDT – Research Report) and Doximity (DOCS – Research Report) with bullish sentiments.

Denali Therapeutics (DNLI)

Leerink Partners analyst Marc Goodman maintained a Buy rating on Denali Therapeutics on March 3 and set a price target of $40.00. The company’s shares closed last Tuesday at $15.95, close to its 52-week low of $14.56.

According to TipRanks.com, Goodman is a 4-star analyst with an average return of 4.1% and a 45.1% success rate. Goodman covers the Healthcare sector, focusing on stocks such as Opthea Limited Sponsored ADR, Intra-Cellular Therapies, and Avadel Pharmaceuticals.

Denali Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $38.79, implying a 156.9% upside from current levels. In a report issued on February 27, TD Cowen also maintained a Buy rating on the stock.

Ardent Health Partners, Inc. (ARDT)

Leerink Partners analyst Whit Mayo reiterated a Buy rating on Ardent Health Partners, Inc. on March 3 and set a price target of $21.00. The company’s shares closed last Tuesday at $15.03.

According to TipRanks.com, Mayo is a 4-star analyst with an average return of 2.8% and a 47.4% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Clover Health Investments, and Pediatrix Medical Group.

Ardent Health Partners, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $20.86, implying a 38.2% upside from current levels. In a report issued on February 27, KeyBanc also maintained a Buy rating on the stock with a $24.00 price target.

Doximity (DOCS)

Leerink Partners analyst Michael Cherny reiterated a Buy rating on Doximity on March 3 and set a price target of $90.00. The company’s shares closed last Tuesday at $67.83.

According to TipRanks.com, Cherny is a 4-star analyst with an average return of 3.4% and a 52.4% success rate. Cherny covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Vertex Pharmaceuticals, and Patterson Companies.

Doximity has an analyst consensus of Moderate Buy, with a price target consensus of $72.50, representing a 6.6% upside. In a report issued on February 18, Robert W. Baird also maintained a Buy rating on the stock with a $87.00 price target.